Tajouri L, Martin V, Gasparini C, Ovcaric M, Curtain R, Lea RA, et al. Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis. Brain Res Bull 2006; 69(3): 327-31.
Corfield F, Langdon D. A systematic review and meta-analysis of the brief cognitive assessment for multiple sclerosis (BICAMS). Neurol Ther 2018; 7(2): 287-306.
Ralli M, Di Stadio A, Visconti IC, Russo FY, Balla MP, Greco A, et al. Otolaryngologic Symptoms in multiple sclerosis: A Review. Int Tinnitus J 2018; 22(2): 160-9.
Farshchian N, Razazian N, Rezaei M, Livani S (MD). Signal intensity of basal ganglions in T2 magnetic resonance imaging in multiple sclerosis. J Gorgan Univ Med Sci 2013; 14(4): 76-81. [In Persian].
Krauss W, Gunnarsson M, Nilsson M, Thunberg P. Conventional and synthetic MRI in multiple sclerosis: A comparative study. Eur Radiol 2018; 28(4): 1692-700.
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17(2): 162-73.
Bagheri MH, Meshksar A, Nabavizadeh SA, Borhani-Haghighi A, Ashjazadeh N, Nikseresht AR. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis. Acad Radiol 2008; 15(1): 15-23.
Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S, et al. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol 2004; 182(5): 1111-4.
Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 2003; 181(6): 1463-71.
Lohmann P, Werner JM, Shah NJ, Fink GR, Langen KJ, Galldiks N. Combined amino acid positron emission tomography and advanced magnetic resonance imaging in glioma patients. Cancers (Basel) 2019; 11(2).
Gass A, Niendorf T, Hirsch JG. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders--biophysical mechanisms and possible underlying histopathology. J Neurol Sci 2001; 186(Suppl 1): S15-S23.
Kearney H, Miller DH, Ciccarelli O. Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value. Nat Rev Neurol 2015; 11(6): 327-38.
Tsuchiya K, Hachiya J, Maehara T. Diffusion-weighted MR imaging in multiple sclerosis: comparison with contrast-enhanced study. Eur J Radiol 1999; 31(3): 165-9.
Radwan MEM, Aboshaera KO. One step diagnosis of multiple sclerosis disease activity, dissemination in time and space using diffusion weighted MRI. Egypt J Radiol Nucl Med 2016; 47(4): 1557-63.
Hoefnagels FW, De Witt HP, Sanz-Arigita E, Idema S, Kuijer JP, Pouwels PJ, et al. Differentiation of edema and glioma infiltration: proposal of a DTI-based probability map. J Neurooncol 2014; 120(1): 187-98.